ROPHARMA BRASOVRR

ROPHARMA BRASOV

0.165ROND
+0.003+1.85%
At close at May 30, 14:04 GMT
RON
No trades
See on Supercharts

RPH fundamentals

Key facts

Market capitalization‪84.36 M‬RON
Basic EPS (TTM)−0.00RON
Founded1952
Employees (FY)‪1.72 K‬
CEOMihai Miron
About

Ropharma SA engages in the production, distribution, and trade of pharmaceuticals. It also offers medical services. The company was founded in 1952 and is headquartered in Brasov, Romania.

Ownership
‪‪511.27 M‬‬
Closely held shares
‪‪321.54 M‬‬ (62.89%)
Free Float shares
‪‪189.73 M‬‬ (37.11%)
Closely held shares
‪‪321.54 M‬‬ (62.89%)
Free Float shares
‪‪189.73 M‬‬ (37.11%)
Capital structure
Market cap
‪‪84.36 M‬‬
Debt
‪‪162.42 M‬‬
Minority interest
‪‪14.12 M‬‬
Cash & equivalents
‪‪19.90 M‬‬
Enterprise value
‪‪240.99 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪84.36 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.06x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.06x
Valuation ratios
‪0.00‬
‪0.03‬
‪0.05‬
‪0.08‬
‪0.10‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪250.00‬
‪500.00‬
‪750.00‬
‪‪1.00 K‬‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−0.6%‬
‪0.0%‬
‪0.6%‬
‪1.2%‬
‪1.8%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Own Pharmacies
Distribution
Medical Services
By country
Period: 2024
Romania

Dividends

Dividend yield, history and sustainability

No dividends
RPH has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−60.00 M‬‬
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Assets
Liabilities